Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer
2019 ◽
2019 ◽
2013 ◽
Vol 10
(Suppl 1)
◽
pp. P38
◽
2002 ◽
Vol 41
(7)
◽
pp. 1174-1178
◽
2010 ◽
Vol 20
(20)
◽
pp. 6129-6132
◽
2012 ◽
Vol 10
(3)
◽
pp. 163-173
◽
2006 ◽
Vol 16
(10)
◽
pp. 2672-2676
◽